CA
NUVB icon

Cliff Asness’s Nuvation Bio NUVB Stock Holding History

Cliff Asness’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4M Buy
2,356,429
+360,671
+18% +$1.76M ﹤0.01% 1391
2026
Q1 		$8.56M Buy
1,995,758
+326,592
+20% +$1.82M ﹤0.01% 1422
2025
Q4 		$15M Sell
1,669,166
-365,045
-18% -$2.26M 0.01% 1046
2025
Q3 		$7.53M Buy
2,034,211
+896,919
+79% +$2.44M ﹤0.01% 1224
2025
Q2 		$2.22M Buy
1,137,292
+1,001,883
+740% +$2.09M ﹤0.01% 1716
2025
Q1 		$238K Sell
135,409
-685,950
-84% -$1.56M ﹤0.01% 2795
2024
Q4 		$2.18M Buy
821,359
+78,922
+11% +$203K ﹤0.01% 1491
2024
Q3 		$1.7M Buy
742,437
+630,854
+565% +$1.92M ﹤0.01% 1577
2024
Q2 		$326K Buy
111,583
+93,233
+508% +$284K ﹤0.01% 2234
2024
Q1 		$66.8K Buy
+18,350
New +$35.2K ﹤0.01% 2366

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Cliff Asness's NUVB Position: Q2 2026 in Review

Cliff Asness increased its Nuvation Bio (NUVB) stake by 18% in Q2 2026, buying an estimated $1.76M and bringing the position to 2,356,429 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Cliff Asness first reported a position in NUVB in Q1 2024 and has held it in 10 quarters since. The position peaked at $15M in Q4 2025. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Cliff Asness held 2,356,429 shares of Nuvation Bio worth $13.4M as of Q2 2026.
  • Cliff Asness bought 360,671 Nuvation Bio shares in Q2 2026, an estimated $1.76M.
  • Nuvation Bio made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1391 holding.
  • Cliff Asness first reported a position in Nuvation Bio in Q1 2024 and has held it in 10 quarters since.
  • Cliff Asness's Nuvation Bio position peaked at $15M in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.